FTC Staff Comment: FDA Should Reevaluate Its Current Regulatory Framework for Homeopathic Products
Date
The staff of the Federal Trade Commission has recommended that the U.S. Food and Drug Administration reconsider the framework it uses to regulate homeopathic medications because it may appear to...